Metropolitan Life Insurance CO Day One Biopharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$11.22 - $14.86 $10,715 - $14,191
955 Added 34.9%
3,691 $45,000
Q2 2023

Aug 10, 2023
BUY
$11.74 - $14.47 $13,994 - $17,248
1,192 Added 77.2%
2,736 $32,000
Q1 2023

May 15, 2023
SELL
$12.75 - $23.41 $3,582 - $6,578
-281 Reduced 15.4%
1,544 $20,000
Q4 2022

Jun 14, 2023
BUY
$18.77 - $22.0 $5,274 - $6,182
281 Added 18.2%
1,825 $39.3 Million
Q3 2022

Jun 14, 2023
BUY
$16.44 - $26.57 $4,619 - $7,466
281 Added 18.2%
1,825 $36.6 Million
Q2 2022

Jun 20, 2023
BUY
$5.72 - $17.9 $1,607 - $5,029
281 Added 18.2%
1,825 $32,000
Q1 2022

Jun 20, 2023
BUY
$9.12 - $17.47 $2,562 - $4,909
281 Added 18.2%
1,825 $18,000
Q1 2022

Mar 30, 2023
SELL
$9.12 - $17.47 $16,516 - $31,638
-1,811 Reduced 49.81%
1,825 $18,000
Q1 2022

May 12, 2022
BUY
$9.12 - $17.47 $16,644 - $31,882
1,825 New
1,825 $18,000
Q4 2021

Feb 15, 2022
SELL
$15.65 - $26.33 $56,903 - $95,735
-3,636 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$20.0 - $27.92 $41,840 - $58,408
2,092 Added 135.49%
3,636 $86,000
Q3 2021

Mar 30, 2023
BUY
$20.0 - $27.92 $36,220 - $50,563
1,811 Added 99.23%
3,636 $86,000
Q3 2021

Nov 15, 2021
BUY
$20.0 - $27.92 $72,720 - $101,517
3,636 New
3,636 $86,000

Others Institutions Holding DAWN

# of Institutions
178
Shares Held
84M
Call Options Held
144K
Put Options Held
218K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $924M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email